Samsung Medical Center, Seoul, Korea.
College of Nursing, Research Institute of Nursing Science, Jeonbuk National University, Jeonju, Korea.
Int J Ment Health Nurs. 2023 Dec;32(6):1713-1723. doi: 10.1111/inm.13197. Epub 2023 Jul 31.
Humankind has responded to the profound medical, economic, social, and cultural consequences of coronavirus disease 2019 (COVID-19) by employing various strategies. However, although individuals with mental disorders, including schizophrenia, have suffered more challenges from the infectious disease spread, they have received inadequate attention and care. Hence, this study aimed to explore the experiences of individuals with schizophrenia coping with COVID-19; one-to-one interviews were conducted with 17 individuals diagnosed with schizophrenia in Korea. The data were analysed using grounded theory methodology. The results showed that individuals with schizophrenia became distanced from the routine care they received before COVID-19, faced a dual threat from their mental illness and the emerging infectious disease, and experienced inequity and paradoxical situations. Nevertheless, they strived to live their daily lives by utilizing non-face-to-face access, seeking support from mental health professionals, and devising self-help measures. Moreover, reflecting on their lives throughout the pandemic after returning to their regular daily lives provided an opportunity for healing and growth. This study's results can provide evidence for treating individuals with schizophrenia and other mental disorders during subsequent infectious disease spread. Practical policies and interventions tailored to their vulnerabilities are required.
人类通过采用各种策略应对 2019 年冠状病毒病（COVID-19）带来的深远的医学、经济、社会和文化后果。然而，尽管包括精神分裂症在内的精神障碍患者在传染病传播中面临更多的挑战，但他们却没有得到足够的关注和照顾。因此，本研究旨在探讨精神分裂症患者应对 COVID-19 的体验；在韩国对 17 名被诊断患有精神分裂症的个体进行了一对一访谈。使用扎根理论方法对数据进行了分析。结果表明，精神分裂症患者在 COVID-19 之前接受的常规护理变得疏远，他们面临着精神疾病和新出现的传染病的双重威胁，并经历了不平等和矛盾的情况。然而，他们通过利用非面对面的访问、寻求心理健康专业人员的支持以及制定自助措施来努力过好自己的日常生活。此外，在回到正常日常生活后，对大流行期间的生活进行反思为康复和成长提供了机会。本研究的结果可为随后传染病传播期间治疗精神分裂症患者和其他精神障碍患者提供证据。需要制定针对他们脆弱性的实际政策和干预措施。
